FDA Clears Advanced AI Software for Ultrasound
The AI-powered Elevate Plus reportedly facilitates standardization of routine ultrasound, improves scan time and bolsters image quality.
The Food and Drug Administration (FDA) has granted 510(k) clearance for Elevate Plus, an AI-enabled software with a variety of features to help streamline routine ultrasound exams.
Philips, the developer of
Other pertinent attributes of Elevate Plus include XRes Pro+, which facilitates enhanced imaging detail with tissue and sharper boundary delineation, and Super Res MVI Pro, which improves visualization of microvascular flow.
“Elevate Plus is a game‑changer for our ultrasound workflow. Automating key measurement tasks allows our sonographers to reduce scanning time by up to 30 percent without sacrificing clinical precision,” said Gretchen Sammy, RDMS, RMSKS, an ultrasound manager at Boston Medical Center. “During our evaluation, measurements were consistently placed exactly where we would expect them—saving time while maintaining the accuracy we rely on.”
















